Aspetar, the renowned Orthopaedic and Sports Medicine Hospital in Qatar, has bolstered its Scientific Advisory Board by appointing five distinguished international experts. This strategic move underscores Aspetar’s commitment to enhancing its scientific and medical capabilities, particularly in sports medicine, orthopaedic surgery, and athlete care.
The newly appointed board members include Dr. Neal El Attrache, Dr. Carly Day, Prof. Andrew M. Jones, Dr. Mathieu Lacome, and Daniel Lewindon. Their diverse expertise spans surgery, athlete medical care, performance science, and applied physiology, positioning Aspetar to further elevate its standards in athlete care and scientific research.
Expertise and Roles
The Scientific Advisory Board will provide independent scientific advice and recommendations to support Aspetar’s clinical services, research initiatives, medical education, and strategic development. Khalid Ali al-Mawlawi, acting director-general of Aspetar, emphasized the significance of this board, stating, “The formation of the Scientific Advisory Board with this distinguished group of international experts represents an important milestone in Aspetar’s journey to uphold the highest standards of medical and scientific excellence.”
Dr. Neal El Attrache, a leading figure in orthopaedic surgery and sports medicine, currently serves as Executive Director of Medical Services for the Los Angeles Rams and the Los Angeles Dodgers. With over three decades of experience, he is recognized for his contributions to elite athlete care.
Dr. Carly Day specializes in athlete health and wellbeing, serving as Head Team Physician for Purdue University Athletics and as a physician for the U.S. Soccer U-20 Women’s National Team. Her experience in integrated athlete care will be invaluable to the board.
Contributions from Leading Academics
Prof. Andrew M. Jones, a prominent expert in exercise physiology, holds a professorship at the University of Exeter and has authored over 400 peer-reviewed publications. His role as Editor-in-Chief of *Medicine & Science in Sports & Exercise* further solidifies his expertise in endurance performance.
Dr. Mathieu Lacome, currently the Director of Performance at Paris Saint-Germain, brings extensive experience in elite football and rugby, focusing on data-driven approaches to athlete development. His insights into training-load frameworks will enhance Aspetar’s performance strategies.
Lastly, Daniel Lewindon serves as Performance Director at Tottenham Hotspur, overseeing medical, sports science, nutrition, and psychology across the club’s teams. His background in elite sports will contribute significantly to the board’s objectives.
This enhancement of the Scientific Advisory Board is expected to not only improve the quality of care provided to athletes but also to align Aspetar with global standards in sports medicine and rehabilitation.
For further details, refer to Gulf Times.
For more sports coverage, visit our Sports section.

